Notably, this study demonstrated that adeno-associated virus (AAV)–mediated delivery of PLA2G4E into the hippocampus led to reverse the memory impairment observed in the APP/PS1 AD mouse model and counteract the loss of synaptic connections, supporting its potential as a therapeutic target (3). The gene discussed is PLA2G4E; the disease is Alzheimer disease.